Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
05/2006
05/18/2006WO2006051079A1 Process for preparing itopride hydrochloride
05/18/2006WO2006024587A8 Hydroxybenzoic acid amides and the use thereof for masking bitter taste
05/18/2006WO2005077945A3 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
05/18/2006US20060106236 Protected and unprotected triols for prostaglandin synthesis
05/18/2006US20060106235 2-allyl-4-hydroxycyclopentanone 3-substituted with 3-hydroxy-5-phenylpentyl- or 3-hydroxy-4-(m-trifluoromethylphenyl)butyl- derivatives in which the hydroxy groups are protected , especially by tetrahydropyranyl groups, and the pentyl or butyl chain may be 2-unsaturated
05/18/2006US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
05/17/2006EP1656340A1 1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof
05/17/2006CN1774293A A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
05/17/2006CN1772749A Fungicides for the control of take-all disease of plants
05/17/2006CN1256314C Non-cyclic 1,3-dicarbonyl PPAR double-activation compound with sugar-reducing lipid-reducing activity and preparation method of its medicinal preparation
05/17/2006CN1256309C Improved method for preparing olefin, non-saturated carboxyl acid and non-saturated nitrile from alkyl
05/16/2006US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor
05/16/2006US7045541 Compounds for the treatment of metabolic disorders
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006US7045139 Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines
05/11/2006WO2005123646A3 Fluoroorganic compounds and anti-fouling treatments
05/10/2006EP1654247A1 Alkynyl aryl carboxamides
05/10/2006EP1654218A2 Matrix metalloproteinase inhibitors
05/10/2006CN1255391C COLCHINOL derivatives as vascular damaging agents
05/09/2006US7041659 Compounds for the treatment of metabolic disorders
05/04/2006WO2006046853A1 Flavour modulating substances
05/04/2006WO2006046593A1 Benzene compound having 2 or more substituents
05/04/2006WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof
05/04/2006WO2006045519A1 Synthesis of phenoxyacetic acid derivatives
05/04/2006WO2006012227A3 Amido compounds and their use as pharmaceuticals
05/04/2006WO2005110395A8 System and device for magnetic drug targeting with magnetic drug carrier particles
05/04/2006WO2005107462A3 Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
05/04/2006US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006CA2585037A1 Synthesis of phenoxyacetic acid derivatives
05/04/2006CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof
05/03/2006EP1652837A1 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them
05/03/2006EP1651592A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
05/03/2006EP1651203A1 Quinoneimines of malonic acid diamides
05/03/2006EP1651163A2 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
05/03/2006CN1765878A (1,3-dichlo-6-trifluomethyl-9-phenanthrene-yl)-3-hydroxylpropionamide derivative preparation method
05/03/2006CN1765877A D-calcium pantothenate synthesis method
05/03/2006CN1765876A Process for preparation of alpha-hydroxycarboxylic acid amides
05/02/2006USRE39088 Amide compounds and use of the same
05/02/2006US7038103 Multifunctional liquid phase carriers used in synthesis of oligonucleotides, peptides, protein nucleic acids and oligosaccharides
05/02/2006US7037939 Compound and derivative of gabapentin
05/02/2006CA2117939C Ceramides, process for their preparation and their uses in cosmetics and in dermopharmacy
04/2006
04/27/2006WO2006044381A2 Cannabinergic lipid ligands
04/27/2006US20060089413 Anthranilic acid amides and derivatives thereof as cosmetic and pharmaceutical agents
04/27/2006US20060089401 Kinase inhibitors
04/27/2006US20060089336 4-Dedimethylamino tetracycline compounds
04/26/2006EP1650190A1 3-aryl-3-methyl-quinoline-2,4-diones, preparation method thereof and pharmaceutical composition containing same
04/26/2006EP1650188A1 Treatment of tumors with RAR alpha selective retinoid compounds in combination with other anti-tumor agents
04/26/2006CN1764635A carboxylic acid compounds
04/26/2006CN1764374A Use of aromatic hydroxy compounds as safeners
04/25/2006US7034182 Compounds to treat Alzheimer's disease
04/25/2006US7034164 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors
04/25/2006US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease
04/25/2006US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors
04/20/2006WO2006042150A1 Diaminoalkane aspartic protease inhibitors
04/20/2006WO2006040645A1 N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
04/20/2006WO2006040136A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
04/20/2006WO2005074912A3 Antiparasitic composition containing an organic amine salt of closantel
04/20/2006WO2005030705A9 Inhibitors of histone deacetylase
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006US20060084702 (2S)-2-ethylphenylpropionic acid derivative
04/20/2006US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/20/2006CA2583015A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
04/20/2006CA2582202A1 Diaminoalkane aspartic protease inhibitors
04/19/2006EP1647545A1 Antiviral protease inhibitors
04/19/2006EP1064275B2 Process for producing simvastatin and/or its derivatives
04/19/2006CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
04/19/2006CN1252038C New derivatives of substituted anilines with herbicidal activity
04/19/2006CN1251671C Beta secretase inhibitors
04/18/2006US7030268 Reacting acid chloride with phenylalanine in solvent comprising potassium hydroxide; for production drugs
04/18/2006CA2207443C Tricyclic compounds
04/13/2006WO2006038606A1 Biaryl derivative
04/13/2006US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/13/2006DE10224847B4 Umsetzungsprodukte aus Mischungen langkettiger Fettsäuren und aliphatischen Diaminen und deren Verwendung Reaction products of mixtures of long-chain fatty acids and aliphatic diamines and their use
04/12/2006EP1644321A2 New benzamides as ppaty modulators
04/12/2006EP1644319A1 Novel halo-substituted active methylene compounds
04/12/2006EP1644318A1 New method for synthesizing ceramide-type compounds
04/12/2006EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
04/12/2006CN1758925A Methods of radiofluorination of biologically active vectors
04/11/2006US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents
04/11/2006US7026500 Halogenated selective androgen receptor modulators and methods of use thereof
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006US7026489 e.g., (9R)-1-{(2'S,8'S,10'S,11'R)-2',8'-dihydroxy-7'-oxo-11'-[(Z)-2-pentenyl]-9'-oxa-4'-azatricyclo[6.3.1.01.5]dodec-5'-en-10'-yl}-9-hydroxy-10-oxoundecanoic acid and N-[9-hydroxy-10-oxo-12(Z),15(Z)-octadecadienoyl]-L-isoleucine.
04/11/2006US7026419 Adhesives and sealants
04/11/2006US7026358 Oral general anesthetics and metabolitically resistant anticonvulsants
04/11/2006CA2217030C Protease inhibiting succinic acid derivatives
04/06/2006WO2006035915A1 Monomer compound, process for producing the same, polymer thereof, and water-based curable composition
04/06/2006WO2006035142A1 Preparation of phenol-amide compounds with antioxidant properties
04/05/2006EP1642887A1 Quaternised fatty acid amidoamines
04/05/2006EP1642880A1 Hsp90 family protein inhibitors
04/05/2006EP1641745A1 Propionamide derivatives useful as androgen receptor modulators
04/05/2006EP1641559A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
04/05/2006EP1140846B1 Aspartic protease inhibitors
04/05/2006EP1041976B1 Polyamide oligomers
04/05/2006EP0897747B1 Nitration or carboxylation catalysts
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1249019C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
04/04/2006US7022880 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid compounds prepared by acylation of a substituted piperidine derivative; intermediates to terfenadine carboxylic acid metabolite and related compounds
04/04/2006CA2258764C Inhibitors of oleamide hydrolase
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 157